Coronavirus India News highlights: The World Health Organization on Wednesday said that clinical trials of the drug hydroxychloroquine will resume, having been suspended pending a safety review in the search for coronavirus treatments.
“On the basis of the available mortality data… the executive group will communicate with the principal investigators in the trial about resuming the hydroxychloroquine arm,” WHO chief Tedros Adhanom Ghebreyesus told a virtual news briefing.
On the other hand, for the first time in nearly two months, the growth rate of infections in India declined. One of the main reasons for the decline in growth at the national level is the fact that Maharashtra, which accounts for more than a third of all cases in India, has been slowing down for more than two weeks now.
Indian Council of Medical Research (ICMR) scientist Dr Nivedita Gupta said that the country is still “very far away from the peak”. In an infectious disease, a peak signifies the point at which the daily case count will start to fall. Over the last few days, over 8,000 new cases have been reported from across the country daily.
In other news, the Ministry of Home Affairs today relaxed Visa regulations for foreign officials as India entered unlock 1.0. The government has allowed foreign businessmen, healthcare professionals and engineers to visit India but they will have to obtain fresh visas.
The total number of coronavirus infections in India crossed the 2 lakh-mark to reach 2,07,614 on Wednesday. This includes 5,815 deaths and 1,00,302 cured/ discharged. As many as 217 people have died in the last 24 hours across the country. India is currently on the 7th spot on the global list of countries worst-hit by Covid-19. Globally, over 6,378,239 cases have been reported, while 3,80,250 people have succumbed to the infection. The United States continues to be the worst-affected nation with 1,831,821 cases and 1,06,180 deaths.